Incidence of hepatocellular carcinoma in chronic hepatitis C patients who were treated with direct acting antiviral agents: A nationwide multicenter prospective cohort study

被引：0
|
作者：
Jang, Eun Sun [1 ]
Kim, Young Seok [2 ]
Kim, In Hee [3 ]
Lee, Youn Jae [4 ]
Cho, Sung Beom [5 ]
Jeong, Sook-Hyang [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med GI Hepatol, Bundanggu, South Korea
[2] Soon Chun Hyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea
[3] Chungbuk Natl Univ Hosp, Dept Internal Med, Chonju, South Korea
[4] Inje Univ, Busan Paik Hosp, Dept Internal Med, Busan, South Korea
[5] Chonnam Natl Univ, Hwasun Hosp, Dept Internal Med, Chungnam, South Korea
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
hepatitis C virus; direct acting antiviral agents; hepatocellular carcinoma; prospective; cohort;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EE-0351 (P
引用
收藏
页码：441 / 441
页数：1
相关论文
共 50 条
  • [1] Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
    Tatsuya Ide
    Hironori Koga
    Masahito Nakano
    Satoru Hashimoto
    Hiroshi Yatsuhashi
    Nobito Higuchi
    Makoto Nakamuta
    Satoshi Oeda
    Yuichiro Eguchi
    Satoshi Shakado
    Shotaro Sakisaka
    Yoko Yoshimaru
    Yutaka Sasaki
    Yuichi Honma
    Masaru Harada
    Masataka Seike
    Tatsuji Maeshiro
    Satoshi Miuma
    Kazuhiko Nakao
    Seiichi Mawatari
    Akio Ido
    Kenji Nagata
    Shuichi Matsumoto
    Yuko Takami
    Tetsuo Sohda
    Tatsuyuki Kakuma
    Takuji Torimura
    Hepatology International, 2019, 13 : 293 - 301
  • [2] Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study
    Ide, Tatsuya
    Koga, Hironori
    Nakano, Masahito
    Hashimoto, Satoru
    Yatsuhashi, Hiroshi
    Higuchi, Nobito
    Nakamuta, Makoto
    Oeda, Satoshi
    Eguchi, Yuichiro
    Shakado, Satoshi
    Sakisaka, Shotaro
    Yoshimaru, Yoko
    Sasaki, Yutaka
    Honma, Yuichi
    Harada, Masaru
    Seike, Masataka
    Maeshiro, Tatsuji
    Miuma, Satoshi
    Nakao, Kazuhiko
    Mawatari, Seiichi
    Ido, Akio
    Nagata, Kenji
    Matsumoto, Shuichi
    Takami, Yuko
    Sohda, Tetsuo
    Kakuma, Tatsuyuki
    Torimura, Takuji
    HEPATOLOGY INTERNATIONAL, 2019, 13 (03) : 293 - 301
  • [3] VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response
    Matono, Tomomitsu
    Tada, Toshifumi
    Nishimura, Takashi
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Ikeda, Naoto
    Shiomi, Hideyuki
    Enomoto, Hirayuki
    Iijima, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2024, 51 (02) : 293 - 300
  • [4] Incidence of de-novo hepatocellular carcinoma after treatment with direct antiviral agents for hepatitis C: A multicenter prospective cohort study from Latin America
    Pinero, F.
    Ridruejo, E.
    Mendizabal, M.
    Alonso, C.
    Varon, A.
    Soza, A.
    Palazzo, A.
    Sixto, M.
    Hernandez, N.
    Schinoni, M. I.
    Ceballos, S.
    Gadea, C.
    Perez, D.
    Reggiardo, M. V.
    Moreno, V.
    Mengarelli, S. E.
    Bruno, A.
    Mendoza, C.
    Vila, J.
    Barreyro, F.
    Zuain, M. G. V.
    Parana Filho, Raymundo
    Silva, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S546 - S547
  • [5] Incidence of hepatocellular carcinoma in patients with hepatitis C treated with direct-acting antivirals agents: results of a long-term prospective study period
    De Santis, Emanuela
    Caioli, Alessandro
    De Angelis, Fernando
    De Santis, Adriano
    JOURNAL OF HEPATOLOGY, 2024, 80 : S829 - S829
  • [6] Hepatocellular Carcinoma Occurrence in Non-Cirrhotic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents
    Hejab, Amal
    Ramo, Aula
    Greib, Bradley
    Mansour, Jonathan
    Salgia, Reena
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1592 - S1592
  • [7] A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C
    Gorgen, A.
    Galvin, Z.
    Huang, A.
    Zhang, W.
    Vinaixa, C.
    Berenguer, M.
    Rubin, A.
    Calatayud, D.
    Mehta, N.
    Terrault, N.
    Selzner, N.
    Sapisochin, G.
    TRANSPLANTATION, 2018, 102 : 183 - 183
  • [8] Direct-acting antivirals improve treatment outcomes in patients with chronic hepatitis C-related hepatocellular carcinoma treated with transarterial chemoembolization: a nationwide, multicenter, retrospective cohort study
    Hyun, Hye Kyung
    Cho, Eun Ju
    Park, Soo Young
    Hong, Young Mi
    Kim, Soon Sun
    Kim, Hwi Young
    Heo, Nae-Yun
    Park, Jung Gil
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Lee, Jeonghoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Tak, Won Young
    Kweon, Young Oh
    Yoon, Ki Tae
    Cho, Mong
    Cheong, Jae Youn
    Park, Seung Ha
    Chon, Hye Yeon
    Chun, Ho Soo
    Lee, Jae Seung
    Lee, HyeWon
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2020, 73 : S612 - S613
  • [9] Eradication of Hepatitis C Virus Infection By IFN-Free Direct-Acting Antiviral Agents Reduces Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis C
    Sezaki, Hitomi
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 68 : 349A - 349A
  • [10] Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
    Leal, Cassia
    Strogoff-de-Matos, Jorge
    Theodoro, Carmem
    Teixeira, Rosangela
    Perez, Renata
    Guarana, Thais
    Pinto, Paulo de Tarso
    Guimaraes, Tatiana
    Artimos, Solange
    VIRUSES-BASEL, 2023, 15 (01):
12345